Article

Vistakon offers Acuminder to Facebook users

Vistakon, Division of Johnson & Johnson Vision Care Inc. and maker of Acuvue brand contact lenses, has launched its Acuminder Facebook application, www.acuminder.com/facebook.

Key Points

Jacksonville, FL-Vistakon, Division of Johnson & Johnson Vision Care Inc. and maker of Acuvue brand contact lenses, has launched its Acuminder Facebook application, http://www.acuminder.com/facebook/.

This newest iteration of the company's free, online Acuminder contact lens compliance service expands its functionality into a multipurpose lifestyle tool available to Facebook's 80 million active users.

Acuminder was introduced last year as a complimentary online service designed to help improve contact lens compliance and eye health for the nation's 38 million contact lens wearers.

Contact lens wearers who do not use Facebook can still register for the free service at http://www.acuminder.com/ and elect to receive an automatic reminder about changing or ordering new contact lenses via e-mail, cell phone text message, or a computer prompt.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.